Acadian Asset Management LLC Regenxbio Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $446,209 - $540,919	21,873 New	21,873 $494,000
Q2 2022 Aug 09, 2022	BUY	$19.35 - $35.04 $344,507 - $623,852	17,804 New	17,804 $440,000
Q3 2019 Nov 07, 2019	SELL	$31.84 - $50.88 $311,331 - $497,504	-9,778 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$42.0 - $59.29 $4.15 Million - $5.86 Million	-98,845 Reduced 91.0%	9,778 $503,000
Q1 2019 May 09, 2019	BUY	$40.82 - $62.45 $3.6 Million - $5.51 Million	88,300 Added 434.48%	108,623 $6.23 Million

Q4 2018 Feb 07, 2019	SELL	$39.11 - $75.15 $1.02 Million - $1.96 Million	-26,084 Reduced 56.21%	20,323 $853,000
Q3 2018 Oct 30, 2018	SELL	$65.0 - $82.15 $1.59 Million - $2.01 Million	-24,459 Reduced 34.51%	46,407 $3.5 Million
Q2 2018 Jul 24, 2018	BUY	$27.2 - $74.35 $1.93 Million - $5.27 Million	70,866 New	70,866 $5.08 Million

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $458M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.